Onset and duration of neuromuscular blockade of 0.6 mg/kg rocuronium is markedly prolonged in children with Duchenne's muscular dystrophy (DMD)

被引:0
|
作者
Munster, T. [1 ]
Wick, S. [1 ]
Schmidt, J. [1 ]
Schmitt, H. J. [1 ]
机构
[1] Univ Hosp, Dept Anesthesiol, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A-563
引用
收藏
页码:138 / 138
页数:1
相关论文
共 12 条
  • [1] Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy
    Wick, S
    Muenster, T
    Schmidt, J
    Forst, J
    Schmitt, HJ
    ANESTHESIOLOGY, 2005, 102 (05) : 915 - 919
  • [2] Reduced dosage of rocuronium (0.3 mg/kg) in children with Duchenne's muscular dystrophy does not lead to a short recovery
    Munster, T.
    Schmidt, J.
    Wick, S.
    Schmitt, H. J.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 138 - 138
  • [3] Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy
    Muenster, Tino
    Forst, Juergen
    Goerlitz, Peter
    Schmitt, Hubert J.
    PEDIATRIC ANESTHESIA, 2008, 18 (03) : 251 - 255
  • [4] The response of patients with Duchenne's muscular dystrophy to neuromuscular blockade with vecuronium
    Ririe, DG
    Shapiro, F
    Sethna, NF
    ANESTHESIOLOGY, 1998, 88 (02) : 351 - 354
  • [5] Onset time and duration of action of rocuronium 0.6 mg/kg in the elderly: a comparison with young adults
    Bjerring, Cecilie
    Arleth, Tobias
    Eriksen, Kirsten
    Albrechtsen, Charlotte
    Madsen, Matias V.
    Rasmussen, Lars S.
    ANESTHESIA AND ANALGESIA, 2020, 130 : 350 - 350
  • [6] Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy
    Schmidt, J
    Muenster, T
    Wick, S
    Forst, J
    Schmitt, HJ
    BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (06) : 769 - 772
  • [7] Increased sensitivity to vecuronium (VEC) in children with Duchenne's Muscular Dystrophy (DMD)
    Ririe, DG
    Shapiro, F
    Sethna, NF
    ANESTHESIOLOGY, 1996, 85 (3A) : A1065 - A1065
  • [8] Rocuronium 0.3 mg.kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy
    Muenster, Tino
    Schmidt, Joachim
    Wick, Stefanie
    Forst, Juergen
    Schmitt, Hubert J.
    PEDIATRIC ANESTHESIA, 2006, 16 (08) : 840 - 845
  • [9] Onset time and duration of action of rocuronium 0.6 mg/kg in patients above 80 years of age: A comparison with young adults
    Bjerring, Cecilie
    Vested, Matias
    Arleth, Tobias
    Eriksen, Kirsten
    Albrechtsen, Charlotte
    Rasmussen, Lars S.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2020, 64 (08) : 1082 - 1088
  • [10] Deflazacort Or Prednisone Treatment for Duchenne Muscular Dystrophy (DMD) Real-World Outcomes at Cincinnati Children's Hospital Medical Center (CCHMC)
    Marden, Jessica
    Santos, Claudio
    Trifillis, Panayiota
    Freimark, Jonathan
    Yao, Zhiwen
    Signorovitch, James
    Tian, Cuixia
    Wong, Brenda
    NEUROLOGY, 2020, 94 (15)